New medications for millions of people dealing with alcohol use disorders, chronic pain, and mood disorders can be developed using spinach. A large protein present in the spinach aids in the development of medications, reveal researchers.
The study, led by researchers from the Purdue University, discovered two peptides which are naturally metabolic products of Rubisco -- a large protein found in many plants like spinach -- that may aid in the development of new medications.
Alcoholism
Alcohol use disorder or alcoholism is an inability to control drinking. It can cause short term and long term physical, as well as psychological effects on the patient.
Advertisement
‘The peptides found in the spinach activate the beneficial pathways to treat the disorders without activating the 'side-effects' pathways.’
Tweet it Now
"These disorders are currently not adequately managed," said Richard van Rijn, Assistant Professor at Purdue.
"Better medications that take a more holistic approach and produce fewer side effects will be beneficial.
"We discovered that these peptides selectively activate the known beneficial pathways without activating the 'side-effect pathways' of the receptor," van Rijn added.
![Mental Health - Neurosis vs Psychosis]( "Mental Health - Neurosis vs Psychosis")
Mental well-being is a concern and abnormal coping of emotions can lead to neurosis or psychosis. Mental illnesses can range from depression, anxiety, phobias to schizophrenia and affective disorders.
The discovery, published in the European Neuropsychopharmacolgy, aims to develop molecules that only activate the cellular signalling pathways associated with their therapeutic effect.
Preclinical studies suggest that the peptides are orally bioavailable and able to penetrate the blood-brain barrier, both of which are necessary for a drug to effectively treat a disorder of the central nervous system, van Rijn said.
The researchers are actively pursuing synthetic and computational strategies to improve these peptides to make them more effective.
The rubiscolin peptides are also being investigated for their ability to regulate dietary intake and are even commercially available in anti-ageing skin products.
Source: IANS
"We discovered that these peptides selectively activate the known beneficial pathways without activating the 'side-effect pathways' of the receptor," van Rijn added.
Mental Health - Neurosis vs Psychosis
Mental well-being is a concern and abnormal coping of emotions can lead to neurosis or psychosis. Mental illnesses can range from depression, anxiety, phobias to schizophrenia and affective disorders.
Advertisement
The discovery, published in the European Neuropsychopharmacolgy, aims to develop molecules that only activate the cellular signalling pathways associated with their therapeutic effect.
Preclinical studies suggest that the peptides are orally bioavailable and able to penetrate the blood-brain barrier, both of which are necessary for a drug to effectively treat a disorder of the central nervous system, van Rijn said.
The researchers are actively pursuing synthetic and computational strategies to improve these peptides to make them more effective.
The rubiscolin peptides are also being investigated for their ability to regulate dietary intake and are even commercially available in anti-ageing skin products.
Source: IANS
Spinach
Surprised why spinach is called a superfood? Spinach offers numerous health benefits and has disease prevention properties.
Advertisement
 Drug Interaction with AlcoholThe effects of alcohol, when consumed with certain drugs, can be life-threatening. Hence it is important to be aware of potential alcohol-drug interactions. | Advertisement
|
Advertisement
Recommended Readings
Latest Alcohol & Drug Abuse News
The United States is currently witnessing its highest overall mortality rates in over a century, driven in part by the surge in drug overdose fatalities.
Deciphering genetic factors in brain responses to METH and COC enables personalized approaches to combat drug abuse.
Giving rats DORA-12 during oxycodone withdrawal reduced future drug-seeking behavior, showing promise for preventing opioid addiction and relapse in humans.
Rising to 9.6% in 2021, daily vaping among New Zealand's 14-year-old students underscores a concerning youth trend.
The research also revealed a 22 percent increase in cadmium levels among marijuana users.
